Success Story: In Just 15 Days, A Turkish Hospitalist Achieves NIW Approval via Premium Processing, Also Thanks to Our Assistance

Client’s Testimonial:

“I wish I had applied earlier, especially given the current priority dates. Many of my residency colleagues recommended Chen Immigration for their professionalism and strong track record of success. They provided thoughtful guidance and helped me present my past and current work in a way that allowed USCIS to clearly understand its significance. The team was kind, responsive, and open to feedback—always willing to incorporate my suggestions into the drafts. It was an important step in my career, and I felt a great sense of relief throughout the process thanks to their support. I’m truly grateful for their help.”

On April 17^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Hospitalist in the Field of Immunotherapies (Approval Notice).

General Field: Immunotherapies

Position at the Time of Case Filing: Hospitalist

Country of Origin: Turkey

State of Residence at the Time of Filing: New York

Approval Notice Date: April 17^th, 2025

Processing Time: 15 days (Premium Processing Requested)

Case Summary:

We are thrilled to announce the successful I-140 approval under the National Interest Waiver (NIW) category for an MD holder who is contributing critical insights at the intersection of patient care, chronic disease pathology, and translational immunotherapy research.

Currently practicing as a hospitalist in the United States, the client’s proposed endeavor focuses on enhancing the understanding of chronic diseases, such as cancer, diabetes, and cardiovascular illnesses, by exploring genetic predispositions, environmental factors, and novel chemopreventive agents. His research aims to improve therapeutic efficacy and reduce public health burdens through innovative, patient-focused strategies.

The petition highlighted his compelling academic and research background, including:

● 175 citations to his body of published work;

● 5 peer-reviewed journal articles and 6 conference abstracts, including publications in top-tier journals in immunology and nuclear medicine;

● A track record of peer-reviewed contributions, with his work being cited in studies across diverse domains such as antiviral therapy, radiopharmacy, and cancer diagnostics.

Notably, one of his articles ranks in the top 10% most cited in the field of Clinical Medicine for its year, underscoring the broad influence of his research. His work has been utilized by peers developing imaging techniques and treatment strategies in both infectious disease and oncology contexts.

The petition also demonstrated that his endeavors align with U.S. interests in advancing critical and emerging technologies, including synthetic biology and genome engineering. His expertise in areas such as monoclonal antibody production and next-generation sequencing further validated his positioning as a key contributor to national healthcare innovation.

Thanks to his proven impact and continued dedication to advancing life-saving medical science, his NIW petition was approved in just 15 days through premium processing, without the need for additional evidence.

We extend our congratulations and look forward to his ongoing contributions to public health and translational medicine.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.